Novartis Meningococcal B Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Novartis Meningococcal B Vaccine, covering 2011-07-08 to 2017-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. [Phase 3]